Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ischemic hepatitis: clinical presentation and pathogenesis.

R K Seeto1, B Fenn, D C Rockey

  • 1Department of Medicine (RKS, BF), Division of Gastroenterology, University of California, San Francisco, San Francisco, California, USA.

The American Journal of Medicine
|September 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Understanding and using AlloSure donor derived cell-free DNA.

Biophysical reviews·2020
Same author

Understanding and using AlloSure donor derived cell-free DNA.

Biophysical reviews·2020
Same author

Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy.

Digestive diseases and sciences·2016
Same author

Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio.

Molecular genetics and metabolism·2013
Same author

Association of mortality with high temperatures in a temperate climate: England and Wales.

Journal of epidemiology and community health·2010
Same author

Liver test patterns in patients with acute calculous cholecystitis and/or choledocholithiasis.

Alimentary pharmacology & therapeutics·2009

Ischemic hepatitis, or shock liver, is not caused by hypotension alone. Underlying heart disease, particularly right-sided heart failure, predisposes the liver to injury during hypotensive events.

Area of Science:

  • Hepatology
  • Cardiology
  • Critical Care Medicine

Background:

  • Ischemic hepatitis (shock liver) pathophysiology is poorly understood.
  • It is commonly believed to result from reduced systemic blood flow during shock.
  • This study investigates its causes and clinical features.

Purpose of the Study:

  • To determine if systemic hypotension or shock alone causes ischemic hepatitis.
  • To identify clinical features associated with ischemic hepatitis.
  • To explore the role of underlying cardiac disease in ischemic hepatitis.

Main Methods:

  • Compared 31 ischemic hepatitis patients with 31 trauma patients experiencing hypotension.
  • Defined ischemic hepatitis by elevated aminotransferase levels (>20x ULN) without other causes.

Related Experiment Videos

  • Recorded clinical and hemodynamic data for both groups.

    • Main Results:

    • No trauma patients developed ischemic hepatitis despite hypotension.
    • Ischemic hepatitis patients had significantly higher peak aminotransferase levels (2,088 IU vs. 78 IU).
    • All ischemic hepatitis patients had underlying heart disease; 94% had right-sided heart failure.

    Conclusions:

    • Hypotension or shock alone does not cause ischemic hepatitis.
    • Severe cardiac disease, leading to hepatic congestion, is a key factor.
    • Right-sided heart failure may predispose the liver to injury during hypotensive events.